产品名称

PD 166793

产品货号

Axon 1271 CAS [199850-67-4] MF C17H18BrNO4SMW 412.30 Purity: 99% Optical purity: >98% ee Soluble in 0.1N NaOH(aq), DMSO, and Ethanol Description Matrix metalloproteinase (MMP) inhibitor References Certificates Categories Extra info H León et al. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br. J. Pharmacol. 2008, 153(4), 676-683. MM Sung et al. Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury. J. Mol. Cel. Cardiol. 2007, 43(4), 429-436. AL Chancey et al. Effects of Matrix Metalloproteinase Inhibition on Ventricular Remodeling Due to Volume Overload. Circulation 2002, 105, 1983-1988. Certificate of Analysis Material Safety Data Sheet Angiogenesis Cell Signaling & Oncology Miscellaneous Pain & Inflammation EC 3.4.24.24 MMP MMP inhibitor Chemical name (S)-2-(4'-Bromo-biphenyl-4-sulfonylamino)-3-methyl-butyric acid Parent CAS No. [199850-67-4] Order Size Unit Price Stock 10 mg €90.00 In Stock

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

PD 166793

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 1271

CAS [199850-67-4]

MF C17H18BrNO4S
MW 412.30

Purity: 99%
Optical purity: >98% ee
Soluble in 0.1N NaOH(aq), DMSO, and Ethanol

PD 166793

Description

Matrix metalloproteinase (MMP) inhibitor

H León et al. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br. J. Pharmacol. 2008, 153(4), 676-683.

MM Sung et al. Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury. J. Mol. Cel. Cardiol. 2007, 43(4), 429-436.

AL Chancey et al. Effects of Matrix Metalloproteinase Inhibition on Ventricular Remodeling Due to Volume Overload. Circulation 2002, 105, 1983-1988.

MMP inhibitor

Chemical name

(S)-2-(4'-Bromo-biphenyl-4-sulfonylamino)-3-methyl-butyric acid

Parent CAS No.

[199850-67-4]

产品资料